Rocket Pharmaceuticals Inc (RCKT) Stock Analysis
Verdict: WATCH (do not buy)
Ample liquidity and deep pipeline progress support a recovery toward $5.00, but heavy insider selling at $4.00+ creates a temporary ceiling.
Investment score: 58/100
Analysis as of
Is Rocket Pharmaceuticals Inc stock worth reviewing? The TradeMates thesis
RCKT remains a high-risk, high-reward gene therapy play with sufficient cash but significant insider selling pressure.
7-factor investment score
- Valuation: 45/100 (weight 20%)
- Financial Health: 75/100 (weight 15%)
- Technical Momentum: 70/100 (weight 15%)
- Earnings Quality: 50/100 (weight 15%)
- Insider Sentiment: 25/100 (weight 10%)
- Analyst Consensus: 80/100 (weight 10%)
- Risk-Adjusted Return: 60/100 (weight 15%)
Rocket Pharmaceuticals Inc opportunities and risks
What speaks for RCKT
- Strong Near-Term Liquidity
What speaks against RCKT
- Aggressive Insider Selling Liquidation
Peers and competitors
- CBIO
- BNTC
- EVMN
- DMAC
- TENX
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| RCKT | n/a | 0.0x | n/a | 0.0% | 0.0% | -40.9% |
| CBIO | n/a | 38.9x | n/a | 100.0% | -1363.9% | -30.8% |
| BNTC | n/a | 0.0x | n/a | 0.0% | 0.0% | -5.8% |
| EVMN | n/a | 17.7x | n/a | 92.8% | -759.9% | -45.5% |
| DMAC | n/a | 0.0x | n/a | 0.0% | 0.0% | -7.0% |
| TENX | n/a | 0.0x | n/a | 0.0% | 0.0% | -13.5% |
| Peer median | n/a | 0.0x | n/a | 0.0% | 0.0% | -13.5% |
Frequently asked questions about Rocket Pharmaceuticals Inc (RCKT)
Is RCKT stock a good investment?
The TradeMates model rates Rocket Pharmaceuticals Inc as WATCH (do not buy) with an investment score of 58/100. RCKT remains a high-risk, high-reward gene therapy play with sufficient cash but significant insider selling pressure. This is algorithmic model output, not personal investment advice.
Is RCKT stock a buy?
The TradeMates model verdict for RCKT is WATCH (do not buy) with an investment score of 58/100. Treat this as a model signal to review, not a personal buy recommendation.